FDA approves trial for wearable artificial kidney

February 10 2014

ATLANTA — The U.S. Food & Drug Administration has approved the start of the first human clinical trials in the United States for the wearable artificial kidney designed by Beverly Hills, Calif.-based Blood Purification Technologies Inc. The announcement was made by Victor Gura, MD, during the opening session on Sunday of the Annual Dialysis Conference taking place in Atlanta.

The device was one of three products related to end-stage renal disease that were awarded a special fast-track to market status in April 2012. The program, called Innovation Pathway, is a new system designed to help medical devices reach patients in a safe, timely, and collaborative manner. An implantable Renal Assist Device (iRAD) being developed by the University of California, San Francisco, and a Hemoaccess Valve System (HVS) designed by Greenville, S.C.-based CreatiVasc Medical were also awarded FDA fast track status

Original article: http://www.nephrologynews.com/articles/110030-fda-approves-trial-for-wearable-artificial-kidney

Recent News

Booster vaccines - Coming soon!
September 14 2021
Young Adult Event 2021 Sept 10-19th via Zoom
August 13 2021
Funding agreed for New Renal Unit at St George’s
August 5 2021
New Unit conference calls Monday 9th Aug & Fri 3rd Sept
August 5 2021
Vaccines for the families of transplant & immunosuppressed patients
August 4 2021

Join Us

Register with us, become a member and subscribe to our newsletters including the latest on the impact of coronavirus for patients at St George’s Hospital.